This website is intended for healthcare professionals

News Analysis

Assessing cardiac chest pain in prescribing practice

There are two broad stages of myocardial ischaemia: the first being stable angina; and the second being acute coronary syndromes, which include unstable angina and myocardial infarction (Paine, 2024).

Use of pharmacogenetics to guide cardiovascular drug prescribing

Clopidogrel is an antiplatelet therapy that is used to prevent myocardial infarction (MI) and stroke in individuals with acute coronary syndrome (ACS) (either managed medically or with PCI), those...

Prescribing indications, issues and concerns surrounding semaglutide

Several glucagon-like peptide receptor agonists used to manage blood glucose levels in people living with type 2 diabetes, have been in short supply globally. This includes glucagon-like peptide-1...

Reclassification and prescribing patterns of gabapentinoids

‘In April 2019, following a public consultation, as well as advice from the Advisory Council of the Misuse of Drugs, gabapentinoids were reclassified as Class C controlled substances and scheduled...

Parkinson's disease and the gut microbiome

A new study led by scientists in Japan analysed the microbiota of people living with Parkinson's, as well as those without, and noted that those with the disease have notably fewer bacterial genes...

Reinforcing the role of early glycaemic control in type 2 diabetes

The landmark UK prospective diabetes glucose-control studies carried out over 20 years, with data from 1977 to 1997 and published in 1998 were the first to show that complications from diabetes are...

New treatment hopes for Alzheimer's disease: A look at recent drug trials

Eli Lilly (2023) created donanemab, noting last year that 47% of participants taking the medication had no clinical progression at one year of the disease. However, the placebo group also had no...

Preventing urinary tract infection and supporting patient catheterisation for mental health

A tool has been developed that requires a health professional to carry out the assessment (Lauridsen et al, 2022). A UTI risk factor model was used as the basis to inform the content included in the...

Treating chronic obstructive pulmonary disease in people with type 2 diabetes

A new study published in the British Medical Journal has examined whether the use of the receptor agonist glucagon-like peptide 1 (GLP-1), dipeptidyl peptidase 4 (DPP-4) inhibitors, and sodium-glucose...

Side effects of decongestants in cold and flu season

As we make our way through cold and flu season, prescribers are likely to encounter many patients with varying degrees of illness from these viruses..

Smoking cessation support and treatment services

In 2021, the British Thoracic Society (BTS, 2022) carried out a national audit of the management of tobacco dependency in acute care trusts, following previous audits in 2019 and 2016. The audit...

New research on treating obesity through medical and behavioural intervention

The New England Journal of Medicine recently published the results of a study examining the efficacy of tirzepatide—a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP